Pages that link to "Q43814653"
Jump to navigation
Jump to search
The following pages link to Pregnancy in a patient with a prosthetic mitral valve. Associated with a fetal anomaly attributed to warfarin sodium (Q43814653):
Displaying 39 items.
- Hematologic abnormalities in pregnancy (Q33493742) (← links)
- Management of anticoagulant therapy during pregnancy in patients with prosthetic heart valves (Q33602513) (← links)
- The congenital warfarin syndrome: a case report (Q33652081) (← links)
- Treatment of Thrombosis of Veins of the Lower Extremities (Q33978052) (← links)
- Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. (Q34811304) (← links)
- Species sensitivities and prediction of teratogenic potential (Q35035971) (← links)
- Chondrodysplasia punctata after warfarin in early pregnancy. Case report and summary of the literature (Q35113947) (← links)
- Foetal warfarin syndrome--a complex airway problem. Case report and review of the literature (Q35661749) (← links)
- Environmental teratogens (Q35662122) (← links)
- Maternal toxicity of drugs and metabolic disorders--a possible etiologic factor in the intrauterine death and congenital malformation: a critique on human data (Q36446902) (← links)
- Teratogenic exposures (Q37902128) (← links)
- Effect of environmental agents on pregnancy outcomes: disturbances of prenatal growth and development (Q37910848) (← links)
- The law and congenital malformations. (Q39745279) (← links)
- Mechanism of known environmental teratogens: drugs and chemicals. (Q39745303) (← links)
- Proceedings: Hazards of maternally administered drugs (Q39874417) (← links)
- Anticoagulants in pregnancy: A review of indications and complications (Q39913313) (← links)
- The Management of Patients with Prosthetic Heart Valves (Q39973864) (← links)
- Anticoagulant and thrombolytic drugs. II. Clinical aspects (Q40001926) (← links)
- Fetal deaths and malformations associated with the use of coumarin derivatives in pregnancy (Q40057371) (← links)
- Teratogenesis: A Review of the Basic Principles with a Discussion of Selected Agents: Part II (Q40084525) (← links)
- Medical treatment of cardiovascular disorders during pregnancy (Q40088644) (← links)
- Antithrombotic drugs: part I (Q40612828) (← links)
- Pregnancy in Patients with Prosthetic Heart Valves (Q42237398) (← links)
- Peripheral venous thrombophlebitis during pregnancy (Q45165156) (← links)
- Cardiovascular management of pregnant women with a heart valve prosthesis (Q46390142) (← links)
- Motherisk rounds. Warfarin embryopathy following low-dose maternal exposure (Q46650743) (← links)
- Detection of human teratogenic agents. (Q52875376) (← links)
- Importance of a multidisciplinary approach and monitoring in fetal warfarin syndrome. (Q53534878) (← links)
- Multiple congenital anomalies associated with oral anticoagulants (Q57752551) (← links)
- Congenital malformations associated with the administration of oral anticoagulants during pregnancy (Q58641870) (← links)
- Editorial: Venous thromboembolism and anticoagulants in pregnancy (Q67337849) (← links)
- Warfarin therapy initiated during pregnancy and phenotypic chondrodysplasia punctata (Q67433092) (← links)
- Cardiac valve prostheses, anticoagulation, and pregnancy (Q67560214) (← links)
- Dextran therapy for pregnancy-associated deep thrombophlebitis (Q70450041) (← links)
- Pregnancy in 6 patients with starr-edwards heart valve prostheses (Q70483268) (← links)
- Congestive heart failure in valvular heart disease in pregnancies with and without valvular prostheses and anticoagulant therapy (Q71064583) (← links)
- Antenatal thromboembolism (Q71426988) (← links)
- Clinical experience with anticoagulant therapy during pregnancy (Q71427006) (← links)
- The Course of Pregnancy in Patients with Artificial Heart Valves Treated with Dipyridamole (Q72439716) (← links)